Answers are grounded in this paper and cite their sources.
In this study, we develop a novel magnesium (Mg)/hydroxyapatite (HA) scaffold loaded with vancomycin (VAN) to provide long-lasting antibacterial activity for bone defect repair in chronic osteomyelitis (CO) in children. Firstly, the VAN-Mg/HA nanoparticles were successfully synthesized, as evidenced by X-ray diffraction analysis. Additionally, the VAN-Mg/HA nanoparticles extended the half-life of VAN by nearly 5-fold. Moreover, our results revealed that the VAN-Mg/HA nanoparticles exhibited a significant antibacterial effect, which was further enhanced with an increase in the concentration of Mg/HA nanoparticles. We also found that the VAN-Mg/HA nanoparticles enhanced the viability and migration of BMSCs, indicating good biocompatibility and osteoconductivity. Furthermore, the VAN-Mg/HA nanoparticles demonstrated higher expression levels of osteogenesis-related genes, such as alkaline phosphatase, RUNX2, and osteocalcin, showing good osteogenic properties. In conclusion, the VAN-Mg/HA scaffolds show great potential for antibiosis and bone regeneration in children with CO.
No takes yet. Share an insight, caveat, or question.
Shang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: